Target intelligence / Profile preview

Class C Cephalosporinase (AmpC)

Target
AmpC
Molecular classification
Enzyme, Hydrolase, Beta-Lactamase
01

Overview

Class C cephalosporinases, also known as AmpC β-lactamases, are enzymes produced by various Gram-negative bacteria. Their primary function is to hydrolyze and inactivate a broad range of β-lactam antibiotics, particularly cephalosporins. These enzymes play a significant role in antibiotic resistance. They are typically encoded by chromosomal genes but can also be found on plasmids. Expression is often inducible. Class C cephalosporinases are widespread among Gram-negative bacteria, including Enterobacter, Citrobacter, Serratia, Proteus, Pseudomonas aeruginosa, and some strains of E. coli, making them major contributors to hospital-acquired infections with multidrug-resistant phenotypes. Classic inhibitors such as clavulanic acid do not inhibit class C enzymes effectively; however, newer agents like avibactam show inhibitory activity.

Other names
AmpC beta-lactamaseClass C β-lactamaseAmpC-type β-lactamasesGroup 1 cephalosporinases
02

Mechanism of action

Antibiotic inactivation

03

Biological functions

Antibiotic resistanceHydrolysis of beta-lactam antibiotics
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Multidrug resistanceHospital-acquired infections
06

Interacting drugs

Penicillins

9 more in the full profile.

Beyond the preview

Go deeper on Class C Cephalosporinase (AmpC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Class C Cephalosporinase (AmpC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call